• MRI Image of Human Brain Close-up

    Research team recognized for traumatic brain injury detection work

    UTMB researchers accepted into the prestigious NSF National I-Corps program

    Read More
  • Picture of Dr. Menon in his lab

    Spotlight on Dr. Ramkumar Menon

    Driven by the impact of translational research, therapies to prevent pre-term birth

    Read More
  • UTMB Awarded $15.6 Million/year NIH Grant for Vaccine Development

    UTMB will conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies to combat high-priority viral pathogens

    Read More

UTMB News

Pictures of Dr. Agenor Limon, associate professor in the department of neurology, and Dr. Junki Maruyama, assistant professor in the department of pathology

UTMB investigators win Dunn Foundation Collaborative Research Award

The Gulf Coast Consortia recently named two University of Texas Medical Branch researchers recipients of the John S. Dunn Foundation Collaborative Research Award which supports research in the quantitative biomedical sciences with research seed grants.

An older man doing push ups on the sidewalk

New drug may help people stay strong as they age

Dr. Stanley Watowich discusses new research at the University of Texas Medical Branch holds promise for helping people maintain strength and mobility as they age.

a clipboard with a white piece of paper is in the foreground, blurry. a teen in a black hoody and jeans sits with his head hunched over and hands clasped, resting on his legs. a plant in a white pot is to the right. there's 2 blurry chairs in the BG

Research programs provide mental health resources for area youth

The Trauma Focused Cognitive Behavioral Therapy and Behavioral Activation programs are free and designed for eligible participants between the ages of eight and 20 who are not currently dealing with a mental health emergency such as psychosis or immediately suicidal thoughts.

UTMB Study Identifies an Anti-Aging Protein as Key to Preventing Vision Loss in Glaucoma

Researchers at the University of Texas Medical Branch recently made a breakthrough in understanding how aging contributes to glaucoma, the second leading cause of irreversible blindness worldwide. Their latest study published in Molecular Therapy highlights the crucial role of the anti-aging protein, Sirt6, for preventing vision loss in millions affected by the disease.

Categories